Ally has over 5 years’ experience in pharmaceutical and market access consultancy.

She has led a range of projects including treatment and competitor landscape analyses, literature reviews, primary research with physicians, patients, payers, and KOLs, value communications, product launch and pricing strategy, and commercial strategy including market size forecasting, due diligence, and LOE planning.

Ally has expertise across a range of therapeutic areas including oncology, inflammatory conditions, cardiovascular, renal, and metabolic disorders, and rare diseases, and she holds an MSc in Drug Discovery and Pharmaceutical Development from UCL, as well as a PhD in Tissue Engineering and Regenerative Medicine from Durham University.